98% Svr12 In Korean And Taiwanese Patients With Chronic Genotype 2 Hcv Infection Receiving 12 Weeks Of Sofosbuvir Plus Ribavirin: Results From An International, Multicenter Phase 3 Study

JOURNAL OF HEPATOLOGY(2015)

引用 4|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要